Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter
Recruiting · NCT06333327 · Observational (researchers observe without assigning treatment) · Lead sponsor: Universitair Ziekenhuis Brussel
View the official record on ClinicalTrials.gov →Interventions studied
Pulmonary vein isolation with the multielectrode radiofrequency balloon catheter
What this trial is about
All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) "Heliostar" (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.
Who can take part
Age range
18 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- symptomatic atrial fibrillation with indication to catheter ablation
Exclusion criteria
- age \<18 years old
- pregnancy
- any contraindications to catheter ablation
Where it is running
1 location listed.
- UZ Brussel Heart Rhythm Management Center - Brussels, Belgium